Skip to content

About us
Technology
Product solutions
Laboratory services
- Discover all Laboratory services
- Immunofluorescence:
Resources
Contact us
Investors

Investors

Business strategy
Market size
Regulatory news
Share price
Financial reports
Financial Calendar
Corporate responsibility report
Glossary
Email alerts

AIM Rule 26

Corporate governance
Significant shareholders
ADR
Advisors

Corporate presentations

ANGLE in the media
Analyst research

Latest report

Interim Report June 2024

Please click the links below to download our Annual and Interim Reports and Financial Statements

Open PDF

For any investor relations queries please contact

investor@angleplc.com

About Us
Technology
Product solutions
Laboratory services
- Discover all Laboratory services
- Immunofluorescence:
Resources
Contact us

Investors

For any investor relations queries please contact

investor@angleplc.com

Method of Analysis: FISH

Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment

Search

Recent Posts

ANGLE present findings on liquid biopsy for DDR biomarkers
ANGLE discuss liquid biopsy advancements at ISTRO24
ANGLE announce new partnership with NuProbe
ANGLE attend ESMO24
ANGLE launch HER2 Assay at World CB & CDX Summit

Recent Comments

No comments to show.

Archives

October 2024
September 2024
July 2024
June 2024
May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
June 2023
May 2023

Categories

Uncategorized

About us
Technology
Product solutions
Laboratory services
Resources
Investors
Contact us

2 Occam Court, Occam Road, Surrey Research Park, Guildford, GU2 7QB, UK +44 (0)1483 343434

5100 Campus Drive, Suite 120, Plymouth Meeting, PA 19462, USA +1 610 233 4712

10 Nugent Road, Surrey Research Park, Guildford, GU2 7AF, UK

© ANGLE plc 2024

Privacy policy
Cookies declaration
Terms & conditions
ISO certificates

Request a meeting with

Full name

Email address

Phone number

Preferred date

Preferred time

I agree that by submitting this form, I accept the website’s terms & conditions of use and privacy policy.